In this visual podcast we explore why Australia is an attractive destination for early-phase clinical trials, highlighting the benefits of speed, quality, and cost-effectiveness.
The expert panel discussion delves into Australia’s unique regulatory pathways, the R&D tax incentives, operational logistics, and how early-phase data supports global drug development.
Titanium dioxide (TiO2) has been a critical excipient in pharmaceuticals for decades, offering exceptional opacity, whiteness, and stability. However, evolving regulatory demands are driving the industry to explore alternatives. Resolian provides advanced analytical and characterization support to guide this transition while ensuring product quality and compliance.
Our Flow Cytometry team have designed a sample processing package that solves the logisitcally challenges with samples.
In a globalized life sciences industry, maintaining consistent quality standards across multiple international sites is a major challenge.
Leading the Way in Secure, Cross-Border Analytical Solutions. We’re committed to delivering seamless scientific expertise that’s globally integrated and locally specialized.
The ELISpot assay stands out as a highly sensitive technique for analyzing immune function. Find out more about Resolian’s capabilites here.
Copyright © 2024 Resolian Inc. All rights reserved.